Sagimet Biosciences Inc.
SGMT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $10 | $7 | $15 | $14 |
| G&A Expenses | $5 | $5 | $5 | $4 |
| SG&A Expenses | $5 | $5 | $5 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $14 | $12 | $20 | $18 |
| Operating Income | -$14 | -$12 | -$20 | -$18 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1 | $2 | $2 | $2 |
| Pre-Tax Income | -$13 | -$10 | -$18 | -$16 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$13 | -$10 | -$18 | -$16 |
| % Margin | – | – | – | – |
| EPS | -0.4 | -0.32 | -0.56 | -0.5 |
| % Growth | -25% | 42.9% | -12% | – |
| EPS Diluted | -0.4 | -0.32 | -0.56 | -0.5 |
| Weighted Avg Shares Out | 32 | 32 | 32 | 32 |
| Weighted Avg Shares Out Dil | 32 | 32 | 32 | 32 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $2 | $2 | $2 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$13 | -$12 | -$20 | -$16 |
| % Margin | – | – | – | – |